HomeXVIVO • STO
add
Xvivo Perfusion AB
Previous close
kr 490.00
Day range
kr 475.00 - kr 489.00
Year range
kr 252.50 - kr 547.00
Market cap
14.99B SEK
Avg Volume
57.61K
P/E ratio
72.20
Dividend yield
-
Primary exchange
STO
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 198.48M | 35.38% |
Operating expense | 127.46M | 24.60% |
Net income | 85.82M | 3,657.31% |
Net profit margin | 43.24 | 2,671.79% |
Earnings per share | 2.86 | 660.77% |
EBITDA | 30.30M | 160.50% |
Effective tax rate | 2.12% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 449.98M | -24.28% |
Total assets | 2.28B | 1.84% |
Total liabilities | 195.02M | -36.89% |
Total equity | 2.08B | — |
Shares outstanding | 31.50M | — |
Price to book | 7.41 | — |
Return on assets | 2.25% | — |
Return on capital | 2.46% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 85.82M | 3,657.31% |
Cash from operations | 22.88M | -7.91% |
Cash from investing | -41.48M | -47.70% |
Cash from financing | -2.62M | -100.61% |
Net change in cash | -30.79M | -107.28% |
Free cash flow | -97.69M | -540.13% |
About
Founded
1998
Website
Employees
161
